
403
Sorry!!
Error! We're sorry, but the page you were
looking for doesn't exist.
Musk reacts to WSJ`s record breaking piece
(MENAFN) In a swift response to a Wall Street Journal (WSJ) article published on Saturday, SpaceX CEO Elon Musk took to his X platform (formerly Twitter) to dismiss what he referred to as a "hit piece." The article in question, titled "Elon Musk Has Used Illegal Drugs, Worrying Leaders at Tesla and SpaceX," delved into concerns raised by purported company executives over Musk's alleged use of illegal substances.
Musk, addressing the WSJ's claims, cited a 2018 incident during a podcast interview with Joe Rogan where he smoked marijuana on camera. He revealed that, following the incident, at the request of NASA, he willingly agreed to three years of random drug testing. Musk emphasized that the tests found no trace quantities of any drugs or alcohol. Concluding his response, he dismissed the WSJ, stating it was "not fit to line a parrot cage for bird" and added a "poop" emoji for emphasis.
The WSJ's article outlined concerns from multiple company executives and board members at both Tesla and SpaceX, alleging worries about Musk's behavior being influenced by the use of illegal drugs. The substances in question reportedly included cannabis, ketamine (for which Musk claims to have a legal prescription), LSD, cocaine, ecstasy, and magic mushrooms. The report suggested that Musk's erratic behavior was a source of concern among company leaders.
Notably, Musk's brother Kimbal and at least one current SpaceX board member were mentioned as individuals who had reportedly taken drugs with Musk. However, the article did not specify whether they were among those expressing concerns about Musk's habits. The report also suggested that Musk had used drugs at private parties worldwide, where attendees were required to sign non-disclosure agreements or surrender their phones.
The swift and direct response from Musk underscores the sensitivity of the allegations made by the WSJ and provides insight into his stance on the matter. As the controversy unfolds, it raises questions about the broader implications of executive behavior on corporate governance and the public image of high-profile figures within the tech industry.
Musk, addressing the WSJ's claims, cited a 2018 incident during a podcast interview with Joe Rogan where he smoked marijuana on camera. He revealed that, following the incident, at the request of NASA, he willingly agreed to three years of random drug testing. Musk emphasized that the tests found no trace quantities of any drugs or alcohol. Concluding his response, he dismissed the WSJ, stating it was "not fit to line a parrot cage for bird" and added a "poop" emoji for emphasis.
The WSJ's article outlined concerns from multiple company executives and board members at both Tesla and SpaceX, alleging worries about Musk's behavior being influenced by the use of illegal drugs. The substances in question reportedly included cannabis, ketamine (for which Musk claims to have a legal prescription), LSD, cocaine, ecstasy, and magic mushrooms. The report suggested that Musk's erratic behavior was a source of concern among company leaders.
Notably, Musk's brother Kimbal and at least one current SpaceX board member were mentioned as individuals who had reportedly taken drugs with Musk. However, the article did not specify whether they were among those expressing concerns about Musk's habits. The report also suggested that Musk had used drugs at private parties worldwide, where attendees were required to sign non-disclosure agreements or surrender their phones.
The swift and direct response from Musk underscores the sensitivity of the allegations made by the WSJ and provides insight into his stance on the matter. As the controversy unfolds, it raises questions about the broader implications of executive behavior on corporate governance and the public image of high-profile figures within the tech industry.

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Manuka Honey Market Report 2024, Industry Growth, Size, Share, Top Compan...
- Modular Kitchen Market 2024, Industry Growth, Share, Size, Key Players An...
- Acrylamide Production Cost Analysis Report: A Comprehensive Assessment Of...
- Fish Sauce Market 2024, Industry Trends, Growth, Demand And Analysis Repo...
- Australia Foreign Exchange Market Size, Growth, Industry Demand And Forec...
- Cold Pressed Oil Market Trends 2024, Leading Companies Share, Size And Fo...
- Pasta Sauce Market 2024, Industry Growth, Share, Size, Key Players Analys...
Comments
No comment